The enzyme forms a precise bond that links the ends of a peptide without needing extra "leader" sequences, which are typically required for enzymes to recognize their targets
Read More Novo Nordisk to launch Wegovy in South Korea mid-October Danish pharma giant Novo Nordisk A/S is set to launch its blockbuster glucagon-like peptide-1 therapy, Wegovy (semaglutide), in South Koreas growing obesity therapeutics market next week, a company official confirmed to BioWorld
Adv Clin Chem 48: 7394
That means trying the medication under medical supervision is often the best way to see what works for you
The FDA also found that some companies obscured the compounded nature of their products or failed to adequately disclose the source of the compounded drug
Quelle: Terruzzi I, Montesano A, Senesi P, Villa I, Ferraretto A, Bottani M, Vacante F, Spinello A, Bolamperti S, Luzi L, Rubinacci A